The path from the lab bench to market in biotech has many hurdles and lots of opportunities. Sometimes too many. Elaine Hamm has experienced all stages of bringing innovation from academia to a successful company and products. She shares a valuable framework on how to overcome the “shiny object syndrome” in biotech.

Elaine did her graduate and post-graduate studies in biochemistry and microbiology. Early on she took the role of technology development at the University of Oklahoma, where she built skills in assessing and spinning out new technologies. After several years at the venture capital company i2E, Elaine became the COO at Accele Biopharma. Elaine is also founder of Ascend BioVentures - pharmaceutical accelerator company. She founded Kirrhos Pharamceuticals and is currently President of Otologic Pharmaceutics, a clinical-stage company developing new treatments for hearing-loss and hearing-related diseases.